Ark Surgical

he FDA-Cleared Safety Standard for Laparoscopic Surgery

  • Stage Product In Market
  • Industry Medical Devices and Equipment
  • Location Nazareth, Israel
  • Currency USD
  • Founded July 2017
  • Employees 9
  • Incorporation Type S-corp
  • Website ark-surgical.com

Company Summary

Ark Surgical is an young MedTech company developing FDA-cleared, single-use tissue containment systems for minimally invasive and robotic surgery.

Its LapBox platform addresses a clear surgical safety need: reducing tissue and cancer cell spread during large-tissue removal.

With 200+ cases, hospital reorders, strong margins, and U.S. traction, Ark is closing its Series A to accelerate U.S. growth.

Team

  • CEO

    Experienced medical device professional with 20 years' experience in developing, manufacturing, and clinical testing medical implants and devices for several biomedical companies

  • CEO of U.S. Operations

    Joseph LaBruzzo is a global medical device executive with 30+ years of experience leading growth, commercialization, M&A, and international expansion. He has led businesses generating $200M+ in revenue and teams of 250+ employees. As President & CEO of U.S. Operations and Board Member at Ark Surgical, he leads U.S. growth, physician partnerships, investor relations, and women’s health innovation.

  • Board

    Keren Leshem is a senior healthcare executive, investor, and board advisor with deep experience in women’s health, medtech, fertility, commercialization, fundraising, and strategic growth. She brings strong expertise in scaling healthcare companies, building partnerships, supporting management teams, and advancing innovation that improves patient care and market adoption.

  • Anne Morrissey
    Board

    Anne Morrissey is a senior women’s health and medtech executive, former CEO of Alydia Health, which achieved a $240M acquisition. As a Board Director at Ark Surgical, she brings deep expertise in single-use medical devices, U.S. commercialization, strategic growth, fundraising, clinical adoption, and building companies toward successful strategic exits.

Advisors

  • Hugh S. Taylor, MD
    Unconfirmed
    Prof. Moti Goldenberg, MD
    Unconfirmed
  • Prof. Sven Becker
    Unconfirmed
    Prof. Vadim Morozov
    Unconfirmed
  • Prof. Michael Nimaroff
    Unconfirmed

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free